Metabolomic Endotype of Asthma

Metabolomics, the quantification of small biochemicals in plasma and tissues, can provide insight into complex biochemical processes and enable the identification of biomarkers that may serve as therapeutic targets. We hypothesized that the plasma metabolome of asthma would reveal metabolic consequences of the specific immune and inflammatory responses unique to endotypes of asthma. The plasma metabolomic profiles of 20 asthmatic subjects and 10 healthy controls were examined using an untargeted global and focused metabolomic analysis. Individuals were classified based on clinical definitions of asthma severity or by levels of fraction of exhaled NO (FENO), a biomarker of airway inflammation. Of the 293 biochemicals identified in the plasma, 25 were significantly different among asthma and healthy controls (p < 0.05). Plasma levels of taurine, lathosterol, bile acids (taurocholate and glycodeoxycholate), nicotinamide, and adenosine-5-phosphate were significantly higher in asthmatics compared with healthy controls. Severe asthmatics had biochemical changes related to steroid and amino acid/protein metabolism. Asthmatics with high FENO, compared with those with low FENO, had higher levels of plasma branched-chain amino acids and bile acids. Asthmatics have a unique plasma metabolome that distinguishes them from healthy controls and points to activation of inflammatory and immune pathways. The severe asthmatic and high FENO asthmatic have unique endotypes that suggest changes in NO-associated taurine transport and bile acid metabolism.

[1]  S. Hazen,et al.  Biomarker-based asthma phenotypes of corticosteroid response. , 2015, The Journal of allergy and clinical immunology.

[2]  B. Gaston,et al.  Nitrogen chemistry and lung physiology. , 2015, Annual review of physiology.

[3]  Subbaya Subramanian,et al.  CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models. , 2015, Canadian journal of physiology and pharmacology.

[4]  A. Bhatnagar,et al.  Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice , 2014, Front. Physiol..

[5]  A. Wu,et al.  Biological variation of β-sitosterol, campesterol, and lathosterol as cholesterol absorption and synthesis biomarkers. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[6]  K. Schulze-Osthoff,et al.  Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome , 2013, Cell Death and Disease.

[7]  H. Ripps,et al.  Review: Taurine: A “very essential” amino acid , 2012, Molecular vision.

[8]  S. Erzurum,et al.  Biomarkers in asthma: a real hope to better manage asthma. , 2012, Clinics in chest medicine.

[9]  S. Chong,et al.  Functional impairment of rat taurine transporter by activation of nitrogen oxide through superoxide. , 2012, Drug metabolism and pharmacokinetics.

[10]  Margaret W Leigh,et al.  An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. , 2011, American journal of respiratory and critical care medicine.

[11]  M. Milburn,et al.  Plasma metabolomic profile in nonalcoholic fatty liver disease. , 2011, Metabolism: clinical and experimental.

[12]  Adnan Custovic,et al.  Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. , 2011, The Journal of allergy and clinical immunology.

[13]  M. Anwer,et al.  Nitric oxide-mediated inhibition of taurocholate uptake involves S-nitrosylation of NTCP. , 2011, American journal of physiology. Gastrointestinal and liver physiology.

[14]  W. Busse,et al.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. , 2010, American journal of respiratory and critical care medicine.

[15]  S. Erzurum,et al.  Redox control of asthma: molecular mechanisms and therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[16]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[17]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[18]  G. Anderson,et al.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.

[19]  A. Michils,et al.  Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients , 2008, European Respiratory Journal.

[20]  David S. Wishart,et al.  Current Progress in computational metabolomics , 2007, Briefings Bioinform..

[21]  C. Brenner,et al.  NAD+ metabolism in health and disease. , 2007, Trends in biochemical sciences.

[22]  S. Pedersen,et al.  Roles of phospholipase A2 isoforms in swelling- and melittin-induced arachidonic acid release and taurine efflux in NIH3T3 fibroblasts. , 2006, American journal of physiology. Cell physiology.

[23]  E. Choleris,et al.  Decreased cADPR and increased NAD+ in the Cd38-/- mouse. , 2006, Biochemical and biophysical research communications.

[24]  T. White,et al.  Regulation of intracellular levels of NAD: a novel role for CD38. , 2006, Biochemical and biophysical research communications.

[25]  S. Hazen,et al.  Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. , 2005, The American journal of pathology.

[26]  M. Walsh,et al.  Metabolomics in human nutrition: opportunities and challenges. , 2005, The American journal of clinical nutrition.

[27]  Steven M. Miller,et al.  Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. , 2004, American journal of respiratory cell and molecular biology.

[28]  I. H. Lambert.  Regulation of the Cellular Content of the Organic Osmolyte Taurine in Mammalian Cells , 2004, Neurochemical Research.

[29]  H. Gylling,et al.  Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment , 2003, European journal of clinical investigation.

[30]  S. Kalhan,et al.  Serine metabolism in human pregnancy. , 2003, American journal of physiology. Endocrinology and metabolism.

[31]  R. Panettieri,et al.  CD38‐cyclic ADP‐ribose‐mediated Ca2+ signaling contributes to airway smooth muscle hyperresponsiveness , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Cortijo,et al.  Taurine and the Lung , 2003 .

[33]  J. Cortijo,et al.  Taurine and the lung: which role in asthma? , 2003, Advances in experimental medicine and biology.

[34]  V. Ganapathy,et al.  Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. , 2001, American journal of physiology. Cell physiology.

[35]  D. Laskowski,et al.  High levels of exhaled nitric oxide (NO) and NO synthase III expression in lesional smooth muscle in lymphangioleiomyomatosis. , 2001, American journal of respiratory cell and molecular biology.

[36]  R. Dweik,et al.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[38]  W. Busse,et al.  Airway remodeling and repair. , 1999, American journal of respiratory and critical care medicine.

[39]  J. Boyer,et al.  Nitric oxide and guanosine 3′,5′‐cyclic monophosphate stimulate bile secretion in isolated rat hepatocyte couplets, but not in isolated bile duct units , 1998, Hepatology.

[40]  J. Kayashita,et al.  Hypercholesterolemic effect in rats of a dietary addition of the nitric oxide synthase inhibitor, L-N omega nitroarginine, by less synthesis of bile acids. , 1998, Bioscience, biotechnology, and biochemistry.

[41]  W. Vogel,et al.  Levels of amino acids and related compounds in bronchoalveolar lavage fluids of asthmatic patients. , 1997, American journal of respiratory and critical care medicine.

[42]  W. Calhoun,et al.  Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. , 1992, The American review of respiratory disease.